a histomorphometric study of the effect of doxycycline and erythromycin on bone formation in dental alveolar socket of rat
Clics: 268
ID: 181058
2015
Metricas de Calidad y Rendimiento del Articulo
Calidad General
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Participacion del Lector
Steady Performance
30.0
/100
268 vistas
27 lectores
Evaluacion de Calidad por IA
No analizado
Readership in this journal
SteadyRanked #48 of 87 articles by views in microbiological research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Resumen
Background: The aim of the present study was to evaluate whether subantimicrobial doses of doxycycline (DOX) and erythromycin (EM) used for the treatment of peri-implant osteolysis due to their anti-osteoclastogenesis can interfere with the osseous wound healing process in rat alveolar socket.
Materials and Methods: Forty-five male Wistar rats had their first maxillary right molar extracted and were divided into three groups. DOX and EM at the doses of 5 mg/kg/day orally (p.o.) and 2 mg/kg/day intraperitoneally (i.p.) were administered respectively to two separate groups for 7 days after operation. In the control group the animals received normal saline (5 ml/kg). Five rats were sacrificed at 7, 14 and 21 days post-extraction in each study group. A histomorphometric analysis was used to evaluate new bone formation inside the alveolar socket. Significant level was set at 0.05.
Results: The findings showed that the percentage of new bone formation (NBF) enhanced significantly on days 7 and 14. There was no significant difference in the NBF between DOX and EM groups.
Conclusion: Short-term treatment with both DOX and EM enhanced new bone formation without any advances in favor of each drug.
| Clave de Referencia |
shahabooei2015advanceda
Use esta clave para autocitar en el manuscrito mientras usa
SciMatic Manuscript Manager o Thesis Manager
|
|---|---|
| Autores | ;Mohammad Shahabooei;Sayed Mohammad Razavi;Mohsen Minaiyan;Reza Birang;Parichehr Behfarnia;Jaber Yaghini;Narges Naghsh;Parichehr Ghalayani;Samira Hajisadeghi |
| Revista | microbiological research |
| Ano | 2015 |
| DOI |
10.4103/2277-9175.153895
|
| URL | |
| Palabras Clave |
Citas
No se encontraron citas. Para agregar una cita, contacte al administrador en info@scimatic.org
Comentarios
Aun no hay comentarios. Sea el primero en comentar este articulo.